These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 26207697)

  • 1. Regulation of 26S Proteasome Activity in Pulmonary Fibrosis.
    Semren N; Welk V; Korfei M; Keller IE; Fernandez IE; Adler H; Günther A; Eickelberg O; Meiners S
    Am J Respir Crit Care Med; 2015 Nov; 192(9):1089-101. PubMed ID: 26207697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azithromycin attenuates myofibroblast differentiation and lung fibrosis development through proteasomal degradation of NOX4.
    Tsubouchi K; Araya J; Minagawa S; Hara H; Ichikawa A; Saito N; Kadota T; Sato N; Yoshida M; Kurita Y; Kobayashi K; Ito S; Fujita Y; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Yoshii Y; Ishikawa T; Numata T; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Nakanishi Y; Kuwano K
    Autophagy; 2017 Aug; 13(8):1420-1434. PubMed ID: 28613983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compromised peroxisomes in idiopathic pulmonary fibrosis, a vicious cycle inducing a higher fibrotic response via TGF-β signaling.
    Oruqaj G; Karnati S; Vijayan V; Kotarkonda LK; Boateng E; Zhang W; Ruppert C; Günther A; Shi W; Baumgart-Vogt E
    Proc Natl Acad Sci U S A; 2015 Apr; 112(16):E2048-57. PubMed ID: 25848047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteasome activator PA200 regulates myofibroblast differentiation.
    Welk V; Meul T; Lukas C; Kammerl IE; Mulay SR; Schamberger AC; Semren N; Fernandez IE; Anders HJ; Günther A; Behr J; Eickelberg O; Korfei M; Meiners S
    Sci Rep; 2019 Oct; 9(1):15224. PubMed ID: 31645612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactic acid is elevated in idiopathic pulmonary fibrosis and induces myofibroblast differentiation via pH-dependent activation of transforming growth factor-β.
    Kottmann RM; Kulkarni AA; Smolnycki KA; Lyda E; Dahanayake T; Salibi R; Honnons S; Jones C; Isern NG; Hu JZ; Nathan SD; Grant G; Phipps RP; Sime PJ
    Am J Respir Crit Care Med; 2012 Oct; 186(8):740-51. PubMed ID: 22923663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy.
    Kurita Y; Araya J; Minagawa S; Hara H; Ichikawa A; Saito N; Kadota T; Tsubouchi K; Sato N; Yoshida M; Kobayashi K; Ito S; Fujita Y; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Yoshii Y; Ishikawa T; Numata T; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Kuwano K
    Respir Res; 2017 Jun; 18(1):114. PubMed ID: 28577568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin attenuates lung fibrosis development via NOX4 suppression.
    Sato N; Takasaka N; Yoshida M; Tsubouchi K; Minagawa S; Araya J; Saito N; Fujita Y; Kurita Y; Kobayashi K; Ito S; Hara H; Kadota T; Yanagisawa H; Hashimoto M; Utsumi H; Wakui H; Kojima J; Numata T; Kaneko Y; Odaka M; Morikawa T; Nakayama K; Kohrogi H; Kuwano K
    Respir Res; 2016 Aug; 17(1):107. PubMed ID: 27576730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNF-α-induced NF-κB activation promotes myofibroblast differentiation of LR-MSCs and exacerbates bleomycin-induced pulmonary fibrosis.
    Hou J; Ma T; Cao H; Chen Y; Wang C; Chen X; Xiang Z; Han X
    J Cell Physiol; 2018 Mar; 233(3):2409-2419. PubMed ID: 28731277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-877-3p targets Smad7 and is associated with myofibroblast differentiation and bleomycin-induced lung fibrosis.
    Wang C; Gu S; Cao H; Li Z; Xiang Z; Hu K; Han X
    Sci Rep; 2016 Jul; 6():30122. PubMed ID: 27444321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hedgehog system machinery controls transforming growth factor-β-dependent myofibroblastic differentiation in humans: involvement in idiopathic pulmonary fibrosis.
    Cigna N; Farrokhi Moshai E; Brayer S; Marchal-Somme J; Wémeau-Stervinou L; Fabre A; Mal H; Lesèche G; Dehoux M; Soler P; Crestani B; Mailleux AA
    Am J Pathol; 2012 Dec; 181(6):2126-37. PubMed ID: 23031257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of PARK2-Mediated Mitophagy in Idiopathic Pulmonary Fibrosis Pathogenesis.
    Kobayashi K; Araya J; Minagawa S; Hara H; Saito N; Kadota T; Sato N; Yoshida M; Tsubouchi K; Kurita Y; Ito S; Fujita Y; Takasaka N; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Kojima J; Shimizu K; Numata T; Kawaishi M; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Kuwano K
    J Immunol; 2016 Jul; 197(2):504-16. PubMed ID: 27279371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aortic carboxypeptidase-like protein (ACLP) enhances lung myofibroblast differentiation through transforming growth factor β receptor-dependent and -independent pathways.
    Tumelty KE; Smith BD; Nugent MA; Layne MD
    J Biol Chem; 2014 Jan; 289(5):2526-36. PubMed ID: 24344132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cysteine-rich protein 1 is regulated by transforming growth factor-β1 and expressed in lung fibrosis.
    Järvinen PM; Myllärniemi M; Liu H; Moore HM; Leppäranta O; Salmenkivi K; Koli K; Latonen L; Band AM; Laiho M
    J Cell Physiol; 2012 Jun; 227(6):2605-12. PubMed ID: 21882188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STAT-3 contributes to pulmonary fibrosis through epithelial injury and fibroblast-myofibroblast differentiation.
    Pedroza M; Le TT; Lewis K; Karmouty-Quintana H; To S; George AT; Blackburn MR; Tweardy DJ; Agarwal SK
    FASEB J; 2016 Jan; 30(1):129-40. PubMed ID: 26324850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained activation of toll-like receptor 9 induces an invasive phenotype in lung fibroblasts: possible implications in idiopathic pulmonary fibrosis.
    Kirillov V; Siler JT; Ramadass M; Ge L; Davis J; Grant G; Nathan SD; Jarai G; Trujillo G
    Am J Pathol; 2015 Apr; 185(4):943-57. PubMed ID: 25660181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LTBP2 is secreted from lung myofibroblasts and is a potential biomarker for idiopathic pulmonary fibrosis.
    Enomoto Y; Matsushima S; Shibata K; Aoshima Y; Yagi H; Meguro S; Kawasaki H; Kosugi I; Fujisawa T; Enomoto N; Inui N; Nakamura Y; Suda T; Iwashita T
    Clin Sci (Lond); 2018 Jul; 132(14):1565-1580. PubMed ID: 30006483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of lung apolipoprotein A-I in idiopathic pulmonary fibrosis: antiinflammatory and antifibrotic effect on experimental lung injury and fibrosis.
    Kim TH; Lee YH; Kim KH; Lee SH; Cha JY; Shin EK; Jung S; Jang AS; Park SW; Uh ST; Kim YH; Park JS; Sin HG; Youm W; Koh ES; Cho SY; Paik YK; Rhim TY; Park CS
    Am J Respir Crit Care Med; 2010 Sep; 182(5):633-42. PubMed ID: 20463180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hedgehog and Wnt/β-catenin system machinery mediate myofibroblast differentiation of LR-MSCs in pulmonary fibrogenesis.
    Chen X; Shi C; Cao H; Chen L; Hou J; Xiang Z; Hu K; Han X
    Cell Death Dis; 2018 May; 9(6):639. PubMed ID: 29844390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of protease-activated receptor-2 in idiopathic pulmonary fibrosis.
    Wygrecka M; Kwapiszewska G; Jablonska E; von Gerlach S; Henneke I; Zakrzewicz D; Guenther A; Preissner KT; Markart P
    Am J Respir Crit Care Med; 2011 Jun; 183(12):1703-14. PubMed ID: 21471103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-145 regulates myofibroblast differentiation and lung fibrosis.
    Yang S; Cui H; Xie N; Icyuz M; Banerjee S; Antony VB; Abraham E; Thannickal VJ; Liu G
    FASEB J; 2013 Jun; 27(6):2382-91. PubMed ID: 23457217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.